PDE-5 Inhibitor Therapy for Erectile Dysfunction Secondary to Nerve-Sparing Radical Retropubic Prostatectomy

The majority of patients receiving therapy for erectile dysfunction (ED) following post-radical retropubic prostatectomy (RRP) are treated with phosphodiesterase (PDE)-5 inhibitors, which seem to have variable efficacy in this population. So far, the only head-to-head trials with PDE-5 inhibitors ha...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Padma-Nathan, Harin
Médium: Artigo
Jazyk:Inglês
Vydáno: MedReviews, LLC 2005
Témata:
Post-Radical Prostatectomy Erectile Dysfunction
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1477594/
https://ncbi.nlm.nih.gov/pubmed/16985896
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky